Drug Targets for Fungal-Associated Respiratory Disorders

Description:
Proteins from the fungus Alternaria have importance in the pathogenesis of some chronic respiratory allergies and disorders.  This technology identifies fungal proteins that are critical for the onset of these diseases and are potential drug targets.
 
US Patent 7,662,400
US Patent 7,887,820
US Patent 7,972,611
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Fungus-Induced Inflammation and Eosinophil Degranulation US Utility *United States 11/580,454 7,662,400 10/13/2006 2/16/2010 3/17/2027
Fungus-Induced Inflammation and Eosinophil Degranulation US Divisional *United States 12/835,592 7,887,820 7/13/2010 2/15/2011 10/13/2026
Fungus-Induced Inflammation and Eosinophil Degranulation US Divisional *United States 12/973,100 7,972,611 12/20/2010 7/5/2011 10/14/2025
Category(s):
Drug Screening
For Information, Contact:
Mike Miller
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9228
mmiller@vtip.org
Inventors:
Christopher Lawrence
Keywords:
Pharmaceuticals & Biotechnology
© 2017. All Rights Reserved. Powered by Inteum